Table: Peptidream - 6-MTH parent results
Feb 13 (Reuters)-
Peptidream Inc.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Dec 31, 2018 Dec 31, 2017 Jun 30, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.02 913 mln
(+121.1 pct) (-21.5 pct)
Operating 555 mln loss 895 mln
Recurring 802 mln loss 764 mln
Net 608 mln loss 534 mln
EPS 4.94 yen loss 4.49 yen
EPS Diluted 4.63 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Peptidream Inc..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T
Recent news on PeptiDream
See all newsTable: Peptidream 6-MTH group results (IFRS)
Brief: Peptidream Inc. - Initiation Of Phase 1 Clinical Trial By Novartis Marks Milestone For Peptidream
Brief: PeptiDream Announces First Dosing Of 64cu-Pd-29,875 In Gastric Cancer Patients
Table: Peptidream -Q1 group results (IFRS)
Brief: Peptidream Announces The Initiation Of Phase 1 Clinical Trial By Its Collaboration Partner